In order to elucidate the clinical homogeneity and severity of the hyperphenylalaninaemias in Poland, a total of 71 children with typical phenylketonuria (PKU) originating from western and northern Poland were screened for 13 mutations in the phenylalanine hydroxylase (PAH) gene. Eighty percent of all PKU alleles tested were found to carry an identified mutation. One mutation, namely the R408W mutation, accounted for more than 63% of mutant PAH alleles in Poland, the other 27% being accounted for by six mutations: IVS12ntl (5%), IVSnt546 (5%), Y414C (4%), R252W (1X5%), R261Q (<1%), and G272ter (< 1%). The predominance of the R408W mutation resulted in a high rate of homozygotes (35-2%) and compound heterozygotes for this mutation in children from western and northern Poland. The frequency and deleterious nature of this mutation probably accounts for the clinical homogeneity and severity of the hyperphenylalaninaemias in Poland. In addition, the high rate of the R408W mutation and its association with mutant haplotype 2 at the PAH locus in Poland give additional support to the Balto-Slavic origin of this mutant gene.
IVSnt546 (5%), Y414C (4%), R252W (1X5%), R261Q (<1%), and G272ter (< 1%). The predominance of the R408W mutation resulted in a high rate of homozygotes (35-2%) and compound heterozygotes for this mutation in children from western and northern Poland. The frequency and deleterious nature of this mutation probably accounts for the clinical homogeneity and severity of the hyperphenylalaninaemias in Poland. In addition, the high rate of the R408W mutation and its association with mutant haplotype 2 at the PAH locus in Poland give additional support to the Balto-Slavic origin of this mutant gene.
(J7 Med Genet 1993; 30:232-4) Phenylketonuria (PKU) is caused by deficiency of the hepatic enzyme phenylalanine hydroxylase (PAH: E.C.1.14. 16 
METHODS
For allele specific oligonucleotide (ASO) screening, amplification primers, ASO probes, and experimental procedures for three reported mutations were as described: (1) R252W,4 (2) R261Q,4 and (3) E280K.5
For detection of the mutations that are known to suppress restriction sites (G272ter, S273F, and A364L), exons 7 and 11 were amplified using intronic primers5 6 (5%), Y414C (4%), R252W (1 5%), R261Q (< 1%), and G272ter (< 1 %). Among the 13 mutations tested, six were not represented in this series (R158Q, R243ter, S273F, E280K, P281L, and AL364). No significant discrepancy in the frequency of mutations appeared when the population of mutant alleles was split into two groups according to the geographical origin of the patients, except for the Y414C mutation (table 2) . Table 3 shows that the 114 mutations identified were distributed among 71 subjects, most of them (45/71) being compound heterozygotes (63 4%). Interestingly, 40/71 children (56-3%) were heterozygous for the R408W Table 4 shows that each mutant RFLP haplotype was associated with only one mutation and also that each mutation was associated with only one RFLP haplotype. Thus, a strict genotype-haplotype association was observed in this series.
DISTRIBUTION OF MUTATIONS IN AFFECTED SUBJECTS

Discussion
The study reported here shows that one single mutation, namely R408W, accounted for more than 60% of PKU alleles in Poland. This mutation is associated with mutant haplotype 2 at the PAH locus in western Poland as originally reported in the Danish population. '4 This association is both inclusive and exclusive, as no other mutation was found associated with haplotype 2 and no other mutant haplotype was found to be associated with the R408W mutation.3 The high rate of the R408W mutation in Poland accounts for the high proportion of homozygotes (35*2%) and compound heterozygotes (56-3%) for this mutation. These data are consistent with previous reports from geographically related areas, namely southern Poland (57%),17 Lithuania (69%), and Czechoslovakia (68%)."8 These results, along with those found in eastern Germany, contrast with the lower frequency of the R408W mutation in northern Europe'5 and 
